ArticleAdvanced materials (Deerfield Beach, Fla.)2026
De Novo Autogenic Engineered Living Functional Materials.
Article in Advanced materials (Deerfield Beach, Fla.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Strength in diversity: unlocking the full potential of engineered living materials with multistrain collaboration.FEMS microbiology reviews · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Autogenic engineered living materials (ELMs) enable the in situ production and engineering of native extracellular matrix (ECM). However, existing autogenic ELMs remain limited in scope and functionality. Here, we present a versatile platform for de novo autogenic functional ELMs, leveraging protein mining, computational modeling, and synthetic biology. By analyzing 33,564 CsgA-like homologs, we identify candidates for de novo ECM protein nanofibers. Using AlphaFold2 and molecular dynamics simulations, we elucidate the structural stability of these β-solenoid proteins. By reprogramming the Escherichia coli curli machinery, we achieve the biosynthesis of CsgA-like ELMs from non-model bacteria, featuring up to a 9-fold increased molecular weight and expanded β-sheet repeat units. Furthermore, we fabricate macroscopic biomaterials with enhanced mechanical properties (a 3-fold increase in storage modulus), and their extracellular fiber networks attenuate UV-C irradiation, extending the survival of embedded cells by 5-fold. We further demonstrate programmable functionalities, including 3D printability and selective binding to nanoparticles and antibodies. This work establishes a powerful framework for discovering, designing, and harnessing natural biomolecular systems to advance next-generation autogenic ELMs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.